Drug
S-amlodipine 2.5mg
S-amlodipine 2.5mg is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 33 (100.0%)
Trials by Status
completed250%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
unknown
Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension
NCT04554303
unknownphase_3
Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
NCT01983735
completedphase_3
Efficacy and Safety of CKD-828 to Stage 2 Hypertension
NCT01634295
completedphase_3
CKD-828 S-Amlodipine Non-Responder Trial
NCT01501253
Clinical Trials (4)
Showing 4 of 4 trials
NCT04554303
Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension
NCT01983735Phase 3
Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
NCT01634295Phase 3
Efficacy and Safety of CKD-828 to Stage 2 Hypertension
NCT01501253Phase 3
CKD-828 S-Amlodipine Non-Responder Trial
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4